课题基金 / 基金详情

Validating a new model for growth hormone receptor activation

Validating a new model for growth hormone receptor activation
验证生长激素受体激活的新模型
批准号:
nhmrc : 351584
负责人:
Prof Michael Waters
金额:
$31.51万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2007-12-31

项目摘要

项目成果

Prof Michael Waters的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Growth hormone is an important hormone therapeutic for treating dwarfism. Recently, many new therapeutic applications for growth hormone have been discovered, particularly in relation to its anabolic actions. These include post surgery recovery, enhanced bone fracture healing, Crohns disease, dilated cardiomyopathy, infertility and ageing. The hormone exerts these actions through its receptor, which is a class1 cytokine receptor, similar to many receptors important in regulating immunity, inflammation, metabolism and cancers. In principle, if we can find out how the GH receptor works, this information would help in designing drugs to treat many immune and inflammatory disorders. With current NHMRC support we have developed a model which describes how GH activates the receptor at a molecular level. The model involves two pre-associated receptors at the cell surface binding to the hormone, with the result that the receptors are rotated relative to each other, and this brings the two JAK2 signalling units attached tothe receptor inside the cell into alignment, so they can activate each other. We can activate the receptor without hormone by artificially rotating it. This model is a prediction based on several techniques, but lacks proof of rotation. There are also a number of issues relating to the need for rigidity in the receptors, so the torque can be transmitted into the cell, since many believe there is no rigidity just above the membrane. We predict there is , but need to prove this. This information is vital for designing small orally active mimics of growth hormone, and for developing GH antagonists, likely to be useful for breast and colon cancer. Finally, we have evidence that the specificity of receptor signalling can be changed by mutating the outer part of the receptor (novel). We believe this can be used to change the activity spectrum of GH, hence decrease side effects, by developing analogs which activate one pathway or the other.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of STAT5 in defining lifespan in mouse models
  • 批准号:
    nhmrc : 1025094
  • 项目类别:
    Project Grants
  • 资助金额:
    $36.49万
  • 财政年份:
    2012
  • 负责人:
    Prof Michael Waters
  • 依托单位:
Research Fellowship - Grant ID:1020317
  • 批准号:
    nhmrc : 1020317
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $55.64万
  • 财政年份:
    2012
  • 负责人:
    Prof Michael Waters
  • 依托单位:
The nuclear growth hormone receptor- its actions and mechanism of nuclear translocation
  • 批准号:
    nhmrc : 455864
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $35.45万
  • 财政年份:
    2007
  • 负责人:
    Prof Michael Waters
  • 依托单位:
Research Fellowship - Grant ID:455858
  • 批准号:
    nhmrc : 455858
  • 项目类别:
    NHMRC Research Fellowships
  • 资助金额:
    $51.07万
  • 财政年份:
    2007
  • 负责人:
    Prof Michael Waters
  • 依托单位:
国内基金
海外基金
脊髓新鉴定SNAPR神经元相关环路介导SCS电刺激抑制恶性瘙痒
  • 批准号:
    82371478
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    焦英甫
  • 依托单位:
tau轻子衰变与新物理模型唯象研究
  • 批准号:
    11005033
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2010
  • 负责人:
    李文君
  • 依托单位:
HIV gp41的NHR区新靶点的确证及高效干预
强子对撞机上新物理信号的多轻子末态研究
  • 批准号:
    10675110
  • 项目类别:
    面上项目
  • 资助金额:
    36.0万元
  • 批准年份:
    2006
  • 负责人:
    蒋一
  • 依托单位: